BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 30606408)

  • 61. FGF23 from bench to bedside.
    Kovesdy CP; Quarles LD
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1168-74. PubMed ID: 26864938
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
    Memon F; El-Abbadi M; Nakatani T; Taguchi T; Lanske B; Razzaque MS
    Kidney Int; 2008 Sep; 74(5):566-70. PubMed ID: 18528324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The couple fibroblast growth factor 23 (FGF23)/Klotho].
    Prié D;
    Ann Biol Clin (Paris); 2015; 73(3):299-304. PubMed ID: 26069066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
    Gutiérrez OM
    J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Klotho and chronic kidney disease.
    Hu MC; Kuro-o M; Moe OW
    Contrib Nephrol; 2013; 180():47-63. PubMed ID: 23652549
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FGF23-αKlotho as a paradigm for a kidney-bone network.
    Kuro-O M; Moe OW
    Bone; 2017 Jul; 100():4-18. PubMed ID: 27847255
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
    Epstein M; Freundlich M
    Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
    Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
    Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hormones and osteoporosis update. FGF23/Klotho and bone metabolism].
    Fukumoto S
    Clin Calcium; 2009 Jul; 19(7):945-50. PubMed ID: 19567989
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Klotho, Aging, and the Failing Kidney.
    Buchanan S; Combet E; Stenvinkel P; Shiels PG
    Front Endocrinol (Lausanne); 2020; 11():560. PubMed ID: 32982966
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FGF23 and klotho at the intersection of kidney and cardiovascular disease.
    Edmonston D; Grabner A; Wolf M
    Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Research progress of fibroblast growth factor 23 in acute kidney injury.
    Zhang L; Qin W
    Pediatr Nephrol; 2023 Jul; 38(7):2013-2022. PubMed ID: 36416954
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of fibroblast growth factor-23 signaling by klotho.
    Kurosu H; Ogawa Y; Miyoshi M; Yamamoto M; Nandi A; Rosenblatt KP; Baum MG; Schiavi S; Hu MC; Moe OW; Kuro-o M
    J Biol Chem; 2006 Mar; 281(10):6120-3. PubMed ID: 16436388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients.
    de Oliveira Neves FM; Araújo CB; de Freitas DF; Arruda BFT; de Macêdo Filho LJM; Salles VB; Meneses GC; Martins AMC; Libório AB
    J Transl Med; 2019 Apr; 17(1):121. PubMed ID: 30971270
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Significance of the anti-aging protein Klotho.
    Dërmaku-Sopjani M; Kolgeci S; Abazi S; Sopjani M
    Mol Membr Biol; 2013 Dec; 30(8):369-85. PubMed ID: 24124751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
    Yanucil C; Kentrup D; Campos I; Czaya B; Heitman K; Westbrook D; Osis G; Grabner A; Wende AR; Vallejo J; Wacker MJ; Navarro-Garcia JA; Ruiz-Hurtado G; Zhang F; Song Y; Linhardt RJ; White K; Kapiloff MS; Faul C
    Kidney Int; 2022 Aug; 102(2):261-279. PubMed ID: 35513125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.